Prolonged or increased CHK1 signaling is also seen in CML patient samples and murine myeloid BCR-Abl+ cell lines upon DNA damage, compared to non-transformed samples (37). Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.